PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

KCL molecular communication system to revolutionise drug delivery

The platform safely and effectively replicates the electric signalling process compounds.

Researchers from the department of engineering at King’s College London (KCL) have developed a first-of-its-kind molecular communication system to revolutionise drug delivery and the detection of dangerous chemicals.

The new system could serve as the foundation for new applications, from new forms of computation to drug delivery.

Published in Nature Communications, the team designed and prototyped the microfluidic molecular communication (MIMIC) platform, which works to send signals in real-time biological environments, such as the human body.

Molecular communications (MC) involve using chemical molecules to exchange information; most MC systems rely on molecules to carry information via a transmitter and a receiver.

Typically used when communication is needed, MC’s materials in electronic devices, including mobile phones, can cause irritation or inflammation when in contact with living tissues and electromagnetic fields in Wi-Fi can affect biological processes, including heartbeat regulation.

To resolve the limitations of MC systems in biomedical applications, researchers used chemical reactions in a microfluidic system for signal processing, replacing the biologically incompatible electronic components.

Comprising three separate chemical reactions to achieve three different signal processing functions, the MIMIC platform can safely and effectively replicate the electric signal processing components.

Additionally, the small size of these systems means they are cheap to produce and carry information in a few molecules to be analysed rapidly.

Researchers then designed a reaction at the transmitter to adjust the width and optimise the transmitted signal.

It resulted in a signal with minimal losses travelling lengths of up to 25m.

Researchers now aim to create a smaller version of the system and adapt it to application-specific chemical reactions.

Team lead, Dr Yansha Deng, reader in engineering at KCL, said: “For the first time, our work has shown that man-made molecular communication devices can process chemical signals without electronic devices and thus be biologically compatible” and “has opened the door to a bevy of biological applications where there previously were none”.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026